Marcus Capone

speaker

994 appearances 2 recordings 2 series first heard Feb 2026 last heard 20 Apr

Marcus Capone’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Apr 2026 with 1.

Appearances

newest first · ▶ plays the moment

The Rich Roll Podcast · In Waves & War: Marcus & Amber Capone On Psychedelic Treatment For Veteran PTSD, Rebuilding Life After War & The Mission To Heal A Generation · 20 Apr 2026 podcast

So those same individuals that are not sure yet are actually, they also actually send us individuals all the time saying, hey, this person tried X, Y, and Z, you really need to take care of them.

So we're seeing that starting to happen.

They are.

They're seeing the future and what they're doing is just like many commercial businesses.

You have the folks that are the startups.

So you have the small pharmaceutical companies that are doing this with- Yeah, there were no big pharmaceutical companies.

No pharmaceutical companies have stepped in and said, we're taking this through the FDA.

So it's all the typical startup biotech companies.

But then as they get through their clinical trials, maybe phase one, maybe now in phase two, that's what we usually see.

They get to phase two.

Now J&J steps in or Merck or Eli Lilly.

So they're jumping on once like the risk has gone away and they're seeing that there's a possibility for this to get through.

So the pharmaceutical companies are coming in.

They're just coming in in later stages of what we're seeing.

I think once the payers realize that this will save money in the long term and maybe not overnight, because as we were talking about earlier, these are expensive treatments, they'll probably continue to be expensive.

But saving an individual from years of suffering, the cost of that, the productivity, the absenteeism, if you're talking about in the workforce,

The ER visits, the payers are going to eventually go, wait a minute, if we give this person psilocybin and all those problems go away, how much money do we save?

So to your point, yes, I think payers are starting to see that in the insurance companies that if they get behind this, then it will save them in the long run.

And I would say, be interested, be curious.

I think we need to be lifelong learners and grow.

Showing 801–820 of 994 · page 41 of 50